11:00 AM EST - Pharmala Biotech Holdings Inc : Announces the filing of a key Patent Cooperation Treaty application, containing 6 Novel Chemical Entities. The application claims priority to, and benefit of a United States provisional patent application filed August 20, 2021. This PCT application disclosed novel compositions of MDMA and analogs thereof which may be used to alleviate the known side effects of MDMA while retaining its efficacy. Pharmala Biotech Holdings Inc
shares C.MDMA are trading unchanged at $0.05.
